CD8A and melanoma: A study about SCLC indicated that about 39.3% of patients had PD-L1 protein positivity, and PD-L1 and CD8 + TILs density were associated with better prognoses in patients with SCLC [40].In other studies, PD-L1/PD-1 is also associated with favorable prognoses in various tumors, such as triple negative breast cancer, melanoma, and colorectal cancer [15, 41, 42].